XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 33,413 $ 41,381 $ 33,159
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 21,117 19,799 20,520
Provision for credit losses 3,050 2,818 1,783
Stock-based compensation expense 7,703 5,959 5,513
Deferred income tax expense (benefit) 3,307 3,036 (692)
Amortization of Intangible Assets 1,401 1,286 1,285
Amortization of debt issuance costs 699 552 576
Amortization and accretion of debt 515 493 439
Loss on extinguishment of debt 0 190 23,807
Net loss on divestitures, disposals and impairment charges 1,191 2,029 847
Net gain on property damage, net of insurance claims (343) (3,471) 0
Gain on sale of excess land (1,407) (155) 0
Changes in operating assets and liabilities that provided (used) cash:      
Accounts and preneed receivables (8,122) (5,358) (4,090)
Inventories, prepaid and other current assets (72) 2,295 (4,449)
Intangible and other non-current assets (3,246) (1,917) (1,181)
Preneed funeral and cemetery trust investments (775) (17,679) (31,349)
Accounts payable 169 (101) 522
Accrued and other liabilities 2,988 (9,120) 3,485
Deferred preneed funeral and cemetery revenue 14,968 1,302 5,010
Deferred preneed funeral and cemetery receipts held in trust (966) 17,685 29,061
Net cash provided by operating activities 75,590 61,024 84,246
Cash flows from investing activities:      
Acquisitions of businesses and real estate (44,500) (33,876) (3,285)
Proceeds from divestitures and sale of other assets 4,132 5,027 7,875
Proceeds from insurance claims 1,403 2,440 7,758
Capital expenditures (18,039) (26,081) (24,883)
Net cash used in investing activities (57,004) (52,490) (12,535)
Cash flows from financing activities:      
Borrowings from the credit facility 86,100 155,400 266,168
Payments against the credit facility (97,700) (120,100) (157,968)
Payment to redeem the 6.625% senior notes due 2026 0 0 (400,000)
Payment of call premium for the redemption of the 6.625% senior notes due 2026 0 0 (19,876)
Proceeds from the issuance of the 4.25% senior notes due 2029 0 0 395,500
Payment of debt issuance costs for the credit facility and 4.25% senior notes due 2029 0 (922) (2,197)
Conversions and maturity of the convertible notes 0 0 (3,980)
Payments on acquisition debt and obligations under finance leases (1,167) (882) (1,331)
Payments on contingent consideration recorded at acquisition date 0 0 (461)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 1,494 1,745 2,644
Taxes paid on restricted stock vestings and exercise of stock options (252) (327) (2,647)
Dividends paid on common stock (6,708) (6,763) (7,264)
Purchase of treasury stock 0 (36,663) (140,040)
Net cash used in financing activities (18,233) (8,512) (71,452)
Net increase in cash and cash equivalents 353 22 259
Cash and cash equivalents at beginning of year 1,170 1,148 889
Cash and cash equivalents at end of year $ 1,523 $ 1,170 $ 1,148